168 related articles for article (PubMed ID: 18243687)
21. Ecteinascidin-743 (ET-743), a natural marine compound, with a unique mechanism of action.
Erba E; Bergamaschi D; Bassano L; Damia G; Ronzoni S; Faircloth GT; D'Incalci M
Eur J Cancer; 2001 Jan; 37(1):97-105. PubMed ID: 11165136
[TBL] [Abstract][Full Text] [Related]
22. Non-homologous end joining is the responsible pathway for the repair of fludarabine-induced DNA double strand breaks in mammalian cells.
de Campos-Nebel M; Larripa I; González-Cid M
Mutat Res; 2008 Nov; 646(1-2):8-16. PubMed ID: 18812179
[TBL] [Abstract][Full Text] [Related]
23. Homologous recombination protects mammalian cells from replication-associated DNA double-strand breaks arising in response to methyl methanesulfonate.
Nikolova T; Ensminger M; Löbrich M; Kaina B
DNA Repair (Amst); 2010 Oct; 9(10):1050-63. PubMed ID: 20708982
[TBL] [Abstract][Full Text] [Related]
24. Guanidine-reactive agent phenylglyoxal induces DNA damage and cancer cell death.
Calderón-Montaño JM; Burgos-Morón E; Orta ML; Pastor N; Perez-Guerrero C; Austin CA; Mateos S; López-Lázaro M
Pharmacol Rep; 2012; 64(6):1515-25. PubMed ID: 23406762
[TBL] [Abstract][Full Text] [Related]
25. Wide-spectrum characterization of trabectedin: biology, clinical activity and future perspectives.
Vincenzi B; Napolitano A; Frezza AM; Schiavon G; Santini D; Tonini G
Pharmacogenomics; 2010 Jun; 11(6):865-78. PubMed ID: 20504257
[TBL] [Abstract][Full Text] [Related]
26. Predicting cisplatin and trabectedin drug sensitivity in ovarian and colon cancers.
Stevens EV; Nishizuka S; Antony S; Reimers M; Varma S; Young L; Munson PJ; Weinstein JN; Kohn EC; Pommier Y
Mol Cancer Ther; 2008 Jan; 7(1):10-8. PubMed ID: 18187810
[TBL] [Abstract][Full Text] [Related]
27. Dephosphorylation of histone gamma-H2AX during repair of DNA double-strand breaks in mammalian cells and its inhibition by calyculin A.
Nazarov IB; Smirnova AN; Krutilina RI; Svetlova MP; Solovjeva LV; Nikiforov AA; Oei SL; Zalenskaya IA; Yau PM; Bradbury EM; Tomilin NV
Radiat Res; 2003 Sep; 160(3):309-17. PubMed ID: 12926989
[TBL] [Abstract][Full Text] [Related]
28. Kinetics of gamma-H2AX focus formation upon treatment of cells with UV light and alkylating agents.
Staszewski O; Nikolova T; Kaina B
Environ Mol Mutagen; 2008 Dec; 49(9):734-40. PubMed ID: 18800352
[TBL] [Abstract][Full Text] [Related]
29. A multistep genomic screen identifies new genes required for repair of DNA double-strand breaks in Saccharomyces cerevisiae.
McKinney JS; Sethi S; Tripp JD; Nguyen TN; Sanderson BA; Westmoreland JW; Resnick MA; Lewis LK
BMC Genomics; 2013 Apr; 14():251. PubMed ID: 23586741
[TBL] [Abstract][Full Text] [Related]
30. Atypical retinoids ST1926 and CD437 are S-phase-specific agents causing DNA double-strand breaks: significance for the cytotoxic and antiproliferative activity.
Valli C; Paroni G; Di Francesco AM; Riccardi R; Tavecchio M; Erba E; Boldetti A; Gianni' M; Fratelli M; Pisano C; Merlini L; Antoccia A; Cenciarelli C; Terao M; Garattini E
Mol Cancer Ther; 2008 Sep; 7(9):2941-54. PubMed ID: 18790775
[TBL] [Abstract][Full Text] [Related]
31. Biology of ovarian cancer and trabectedin mechanism of action.
Ray-Coquard I
Future Oncol; 2013 Dec; 9(12 Suppl):11-7. PubMed ID: 24195525
[TBL] [Abstract][Full Text] [Related]
32. The unique biological features of the marine product Yondelis (ET-743, trabectedin) are shared by its analog ET-637, which lacks the C ring.
Erba E; Cavallaro E; Damia G; Mantovani R; Di Silvio A; Di Francesco AM; Riccardi R; Cuevas C; Faircloth GT; D'Incalci M
Oncol Res; 2004; 14(11-12):579-87. PubMed ID: 15666999
[TBL] [Abstract][Full Text] [Related]
33. [Trabectedin (ET-743/Yondelis) for treating soft tissue sarcomas and ovarian cancer].
Gennigens C; Jerusalem G
Rev Med Liege; 2011; 66(7-8):452-5. PubMed ID: 21942081
[TBL] [Abstract][Full Text] [Related]
34. Characterization of a new trabectedin-resistant myxoid liposarcoma cell line that shows collateral sensitivity to methylating agents.
Uboldi S; Bernasconi S; Romano M; Marchini S; Fuso Nerini I; Damia G; Ganzinelli M; Marangon E; Sala F; Clivio L; Chiorino G; Di Giandomenico S; Rocchi M; Capozzi O; Margison GP; Watson AJ; Caccuri AM; Pastore A; Fossati A; Mantovani R; Grosso F; Tercero JC; Erba E; D'Incalci M
Int J Cancer; 2012 Jul; 131(1):59-69. PubMed ID: 21805478
[TBL] [Abstract][Full Text] [Related]
35. Homologous recombination but not nucleotide excision repair plays a pivotal role in tolerance of DNA-protein cross-links in mammalian cells.
Nakano T; Katafuchi A; Matsubara M; Terato H; Tsuboi T; Masuda T; Tatsumoto T; Pack SP; Makino K; Croteau DL; Van Houten B; Iijima K; Tauchi H; Ide H
J Biol Chem; 2009 Oct; 284(40):27065-76. PubMed ID: 19674975
[TBL] [Abstract][Full Text] [Related]
36. Trabectedin efficacy in Ewing sarcoma is greatly increased by combination with anti-IGF signaling agents.
Amaral AT; Garofalo C; Frapolli R; Manara MC; Mancarella C; Uboldi S; Di Giandomenico S; Ordóñez JL; Sevillano V; Malaguarnera R; Picci P; Hassan AB; De Alava E; D'Incalci M; Scotlandi K
Clin Cancer Res; 2015 Mar; 21(6):1373-82. PubMed ID: 25609059
[TBL] [Abstract][Full Text] [Related]
37. In vitro radiosensitisation by trabectedin in human cancer cell lines.
Romero J; Zapata I; Córdoba S; Jimeno JM; López-Martín JA; Tercero JC; De La Torre A; Vargas JA; Molerón R; Sánchez-Prieto R
Eur J Cancer; 2008 Aug; 44(12):1726-33. PubMed ID: 18501589
[TBL] [Abstract][Full Text] [Related]
38. Defining the roles of nucleotide excision repair and recombination in the repair of DNA interstrand cross-links in mammalian cells.
De Silva IU; McHugh PJ; Clingen PH; Hartley JA
Mol Cell Biol; 2000 Nov; 20(21):7980-90. PubMed ID: 11027268
[TBL] [Abstract][Full Text] [Related]
39. Trabectedin for the treatment of breast cancer.
D'Incalci M; Zambelli A
Expert Opin Investig Drugs; 2016; 25(1):105-15. PubMed ID: 26592307
[TBL] [Abstract][Full Text] [Related]
40. BRCA2 is needed for both repair and cell cycle arrest in mammalian cells exposed to S23906, an anticancer monofunctional DNA binder.
Rocca CJ; Soares DG; Bouzid H; Henriques JA; Larsen AK; Escargueil AE
Cell Cycle; 2015; 14(13):2080-90. PubMed ID: 25945522
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
